Efficacy and Safety Study of F373280 for Maintenance of Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation and Chronic Heart Failure. International, Multicentric, Randomised, Double-blind, Placebo Controlled Study.

Trial Profile

Efficacy and Safety Study of F373280 for Maintenance of Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation and Chronic Heart Failure. International, Multicentric, Randomised, Double-blind, Placebo Controlled Study.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 30 May 2017

At a glance

  • Drugs F 373280 (Primary)
  • Indications Atrial fibrillation
  • Focus Therapeutic Use
  • Sponsors Pierre Fabre
  • Most Recent Events

    • 27 May 2017 Trial has been completed in Czech Republic (end date: 3 Apr 2017).
    • 25 May 2017 Trial has been completed in Spain.
    • 08 Nov 2016 Status changed from discontinued to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top